Inequality is fueling drug resistance across the African continent

The bacteria that causes cholera is evolving to become more resistant to drugs that treat the illness.

In Kenya, for example, strains with extended-spectrum beta-lactamase resistance — which are extremely drug resistant — made their first presence in the East African country just over a decade ago, Samuel Kariuki, eastern Africa director for the Drugs for Neglected Diseases initiative, or DNDi, told an audience at a recent public health conference in Zambia.

These strains are more persistent in the environment than their predecessors and outbreaks hit when least expected, including during the dry season — which can come as a shock for a water-borne illness. 

This article is free to read - just register or sign in

Access news, newsletters, events and more.

Join us